Squamous Carcinoma Withdrawn Phase 1 / 2 Trials for Alpelisib (DB12015)

Also known as: Carcinoma, Squamous

IndicationStatusPhase
DBCOND0076732 (Squamous Carcinoma)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02298595Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell CarcinomaTreatment